AU2007307254A1 - Stabilized therapeutic small helical antiviral peptides - Google Patents

Stabilized therapeutic small helical antiviral peptides Download PDF

Info

Publication number
AU2007307254A1
AU2007307254A1 AU2007307254A AU2007307254A AU2007307254A1 AU 2007307254 A1 AU2007307254 A1 AU 2007307254A1 AU 2007307254 A AU2007307254 A AU 2007307254A AU 2007307254 A AU2007307254 A AU 2007307254A AU 2007307254 A1 AU2007307254 A1 AU 2007307254A1
Authority
AU
Australia
Prior art keywords
peptide
amino acids
capsid
mammal
containing virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007307254A
Other languages
English (en)
Inventor
Asim Kumar Debnath
Hongtao Zhang
Qian Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Blood Center Inc
Original Assignee
New York Blood Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Center Inc filed Critical New York Blood Center Inc
Publication of AU2007307254A1 publication Critical patent/AU2007307254A1/en
Priority to AU2012200580A priority Critical patent/AU2012200580A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2007307254A 2006-10-05 2007-10-02 Stabilized therapeutic small helical antiviral peptides Abandoned AU2007307254A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2012200580A AU2012200580A1 (en) 2007-10-02 2012-02-02 Stabilized therapeutic small helical antiviral peptides

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84955106P 2006-10-05 2006-10-05
US60/849,551 2006-10-05
PCT/US2007/021156 WO2008045238A2 (en) 2006-10-05 2007-10-02 Stabilized therapeutic small helical antiviral peptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2012200580A Addition AU2012200580A1 (en) 2007-10-02 2012-02-02 Stabilized therapeutic small helical antiviral peptides

Publications (1)

Publication Number Publication Date
AU2007307254A1 true AU2007307254A1 (en) 2008-04-17

Family

ID=39283347

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007307254A Abandoned AU2007307254A1 (en) 2006-10-05 2007-10-02 Stabilized therapeutic small helical antiviral peptides

Country Status (8)

Country Link
US (1) US8940864B2 (cg-RX-API-DMAC7.html)
EP (2) EP2073829B1 (cg-RX-API-DMAC7.html)
JP (1) JP2010505831A (cg-RX-API-DMAC7.html)
AU (1) AU2007307254A1 (cg-RX-API-DMAC7.html)
CA (1) CA2665186A1 (cg-RX-API-DMAC7.html)
ES (1) ES2387827T3 (cg-RX-API-DMAC7.html)
WO (1) WO2008045238A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200901248B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8937154B2 (en) 2006-10-05 2015-01-20 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
CA2677045C (en) 2007-01-31 2016-10-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
KR20160061439A (ko) 2007-03-28 2016-05-31 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 스티칭된 폴리펩티드
JP2011522796A (ja) * 2008-05-06 2011-08-04 ニューヨーク ブラッド センター， インコーポレイテッド 抗ウイルス細胞透過性ペプチド
BRPI0918833A2 (pt) * 2008-09-22 2015-12-08 Aileron Therapeutics Inc macrociclos peptidomiméticos
BRPI1006139A2 (pt) 2009-01-14 2017-05-30 Aileron Therapeutics Inc macrociclos peptidomiméticos
MX355543B (es) 2010-08-13 2018-04-20 Aileron Therapeutics Inc Star Macrociclos peptidomiméticos.
RU2639523C2 (ru) 2011-10-18 2017-12-21 Эйлерон Терапьютикс, Инк. Пептидомиметические макроциклы и их применение
JP6450191B2 (ja) 2012-02-15 2019-01-09 エイルロン セラピューティクス，インコーポレイテッド ペプチドミメティック大環状化合物
HK1205454A1 (en) 2012-02-15 2015-12-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
US9604919B2 (en) 2012-11-01 2017-03-28 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
SG11201702223UA (en) 2014-09-24 2017-04-27 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
WO2016049355A1 (en) 2014-09-24 2016-03-31 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
US10308684B2 (en) 2014-11-28 2019-06-04 Seoul National University R&Db Foundation Cell penetrating stapled peptide, manufacturing method therefor, and use thereof
EP3294318A4 (en) 2015-03-20 2019-04-03 Aileron Therapeutics, Inc. PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
US10059741B2 (en) 2015-07-01 2018-08-28 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
WO2017018595A1 (ko) * 2015-07-28 2017-02-02 동국대학교 산학협력단 이중 스테이플화된 펩타이드 및 이의 용도
JP2018528217A (ja) 2015-09-10 2018-09-27 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． Ｍｃｌ−１のモジュレーターとしてのペプチド模倣大環状分子
WO2019133179A2 (en) * 2017-12-01 2019-07-04 Massachusetts Institute Of Technology Solution-phase affinity selection of inhibitors from combinatorial peptide libraries
US20200102356A1 (en) * 2018-10-01 2020-04-02 NMC Inc. Compositions and Methods for the Treatment of Huanglongbing (HLB) aka Citrus Greening in Citrus Plants
WO2022036049A2 (en) * 2020-08-12 2022-02-17 New York Blood Center, Inc. Antiviral stapled peptides against sars-cov-2

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187548B1 (en) * 1993-05-23 2001-02-13 Rhone-Poulenc Rorer Pharmaceuticals Inc. Methods using human calcium sensor protein, fragments thereof and DNA encoding same
US6239270B1 (en) * 1993-05-24 2001-05-29 Rhone-Poulenc Rorer S.A. Nucleic acids encoding human calcium sensor protein
US6790950B2 (en) * 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
JP4892134B2 (ja) * 1999-04-09 2012-03-07 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌ワクチン組成物
US7192713B1 (en) * 1999-05-18 2007-03-20 President And Fellows Of Harvard College Stabilized compounds having secondary structure motifs
US20020124273A1 (en) * 2000-10-17 2002-09-05 Jean-Marc Roch Protein-protein interactions in neurodegenerative diseases
CA2830063C (en) * 2003-11-05 2017-10-31 Dana-Farber Cancer Institute, Inc. Stabilized alpha helical peptides and uses thereof
US20100159477A1 (en) * 2006-07-13 2010-06-24 Peter Hornbeck Reagents for the detection of protein phosphorylation in signaling pathways
WO2008008998A2 (en) * 2006-07-13 2008-01-17 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in signaling pathways
EP2061487A4 (en) * 2006-09-11 2009-12-02 Univ Illinois MODIFIED CUPREDOXIN-DERIVED PEPTIDES AND METHOD FOR THEIR USE
CA2677045C (en) 2007-01-31 2016-10-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
JP5078401B2 (ja) * 2007-03-27 2012-11-21 株式会社Ａｄｅｋａ 防水シート
WO2009042237A2 (en) * 2007-09-26 2009-04-02 Dana Farber Cancer Institute Methods and compositions for modulating bcl-2 family polypeptides
CA2713089C (en) * 2008-01-23 2017-11-21 Dana Farber Cancer Institute Compositions and methods for the treatment of viral infections
JP2011522796A (ja) * 2008-05-06 2011-08-04 ニューヨーク ブラッド センター， インコーポレイテッド 抗ウイルス細胞透過性ペプチド
US20110218155A1 (en) * 2008-10-10 2011-09-08 Dana-Farber Cancer Institute, Inc. Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides

Also Published As

Publication number Publication date
CA2665186A1 (en) 2008-04-17
EP2517720A1 (en) 2012-10-31
EP2073829A2 (en) 2009-07-01
ES2387827T3 (es) 2012-10-02
WO2008045238A3 (en) 2008-07-24
US20100130430A1 (en) 2010-05-27
US8940864B2 (en) 2015-01-27
WO2008045238A2 (en) 2008-04-17
JP2010505831A (ja) 2010-02-25
ZA200901248B (en) 2010-04-28
EP2073829A4 (en) 2010-03-03
EP2073829B1 (en) 2012-06-20

Similar Documents

Publication Publication Date Title
US8940864B2 (en) Stabilized therapeutic small helical antiviral peptides
Zhang et al. A cell-penetrating helical peptide as a potential HIV-1 inhibitor
US8933019B2 (en) Antiviral cell-penetrating peptides
DK2320927T3 (en) Modified peptides as potent inhibitors of the PSD-95 / NMDA receptor interaction
JP2011522796A5 (cg-RX-API-DMAC7.html)
NZ570300A (en) HIV fusion inhibitor peptides with improved biological properties
CN111643656A (zh) 广谱冠状病毒膜融合抑制剂及其抗艾滋病病毒的应用
JPH10502337A (ja) Ｈｉｖの細胞侵入を阻害するための、 ｄｐｐｉｖの基質であるペプチド類縁体、特にｋｐｒ型の該類縁体の複合提示
CN106749558B (zh) 广谱抑制hiv的脂肽、其衍生物、其药物组合物及其用途
US8937154B2 (en) Stabilized therapeutic small helical antiviral peptides
WO2013075594A1 (zh) 人工设计的抗hiv感染多肽、组合物以及用途
US20200115418A1 (en) Anti-hiv peptides
CN117120459A (zh) 抗感染双环肽配体
WO2007068163A1 (en) Hiv fusion inhibitor peptides and use thereof
AU2012200580A1 (en) Stabilized therapeutic small helical antiviral peptides
CA2766417A1 (en) Stabilized therapeutic small helical antiviral peptides
CN104159914A (zh) Hiv膜融合抑制剂
Cai et al. Peptides and peptidomimetics as tools to probe protein-protein interactions–disruption of HIV-1 gp41 fusion core and fusion inhibitor design
WO2016094518A2 (en) Novel cyclic peptides and methods using same
WO2012139519A1 (zh) 环肽及其医药用途
US20250325672A1 (en) Anti-infective bicyclic peptide ligands
WO2005068492A2 (en) Peptide inhibitors of retroviral integrase useful for the treatment of retroviral infection

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application